Researchers reported: “For the first time, we show a statistically significant negative association between recreational access to cannabis and OTC sleep aid sales.”
The occasional use of cannabis during late adolescence is not independently associated with adverse effects on cognitive abilities in young adulthood, according to longitudinal data published in the journal Drug and Alcohol Dependence. A team of investigators affiliated with the University of Colorado at Boulder assessed the impact of cannabis use on cognition, executive function, and working memory in 856 individual twins. Cannabis consumers were compared to their non-using twins in late adolescence and then again in their early twenties. Most of the cannabis consuming participants in the study reported occasional use of the substance, but not daily use. Authors found “little support for a causal effect of cannabis use on cognition. This conclusion is consistent with those from previous…
Authors reported “an independent negative association between frequent cannabis use and frequent illicit opioid use.” Specifically, subjects who consumed cannabis daily “had about 50 percent lower odds of using illicit opioids every day [as] compared to cannabis non-users.”
CBD-infused products sold online frequently possess significantly lower percentages of CBD than advertised, according to a report published by the online watchdog group LegitScript.com. Investigators lab-tested 30 CBD products obtained from leading online retailers. Twenty of the thirty products possessed significant deviations in CBD content as compared to what was advertised. Sixteen of the 20 products contained lower percentages of CBD than the amount stated on the product’s label — a finding that is consistent with prior analyses. Some of the products also tested positive for the presence of solvent residue and elevated levels of heavy metals – findings that are also consistent with those of other studies. Authors also evaluated the marketing practices of 300 leading online CBD retailers….
“Individuals who report having pain limiting that limits their daily activity see large health improvements. This is the strongest evidence that a group with a high probability of pain medication use sees large benefits from medical marijuana laws.”
On Wednesday, October 23rd, members of the Senate Senate International Narcotics Control Caucus (aka the Drug Caucus) will hold a hearing entitled “Marijuana and America’s Health: Questions and Issues for Policy Makers.”
A federal court on Friday denied a petition for a writ of mandamus that sought to order the US Drug Enforcement Administration to begin licensing private entities that wish to cultivate cannabis.
The enactment of adult-use marijuana legalization laws is not associated with any significant increase in cannabis-related activity in neighboring states and counties, according to a federally funded report published by the nonprofit Justice Research and Statistics Association.
Updated data provided today by the US Centers for Disease Control reports over 800 cases of acute respiratory distress linked to the use of portable vapor cartridges used to consume certain e-liquids. Of the products tested thus far by the US Food and Drug Administration, about half have identified the presence of Vitamin E acetate.
We also spoke with her attorneys, who explained why they believed the DEA broke the law by holding up long-promised medical marijuana research licenses.